Deep brain stimulation (DBS) has emerged as a standard of care in the treatment of Parkinson’s disease and other movement disorders, such as dystonia and ...

The deal positions Boston Scientific to compete with Medtronic for a market that analysts believe is highly under-penetrated.

Boston Scientific announced multiple recalls but has said its battery issues were limited. One internal test in 2025 found batteries with an “extremely high failure rate.” Credit...Illustration by Mel ...

Boston Scientific has contracted by over 30% over the past year, grossly underperforming other medical equipment stocks and healthcare stocks from the S&P 500. Yet, amidst the ongoing pressure, we are ...

Add Yahoo as a preferred source to see more of our stories on Google. Fireworks executive says company reflexively searches its records when terror cases mention ...

In a world first, China has approved a brain implant for commercial use in people with spinal cord injuries. The device is a type of brain-computer interface (BCI) and is made by the Shanghai-based ...

MISSION TO HELP OTHERS GET BETTER BY THE MILE. IT’S HARD NOT TO SEE THEM AS A COMPLETELY NORMAL FAMILY, AND IN SO MANY WAYS THEY ARE. BUT FOR SHAYLA AND CHRISTIAN GEAVES, THE PATH TO THIS KIND OF JOY ...

Researchers at Brown University have demonstrated that targeted electrical stimulation of the spinal cord can restore both voluntary movement and sensory feedback in people with chronic, ...

NEW YORK, March 26, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX).

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The developer of a new state ...

Boston Beer is rated a weak BUY after its valuation reset post-hard seltzer boom, now trading at a reasonable level versus peers. SAM’s operational efficiency, notably its industry-leading asset ...